VistaGen Therapeutics is a multi-asset, clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and certain CNS diseases and disorders where current treatments are inadequate, resulting in high unmet need. VistaGen's pipeline is focused on clinical-stage CNS drug candidates with a differentiated mechanism of action, an exceptional safety profile, and therapeutic potential in multiple large and growing CNS markets.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
PH94B Neuroactive Nasal Spray
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):